MedPath

Comparison of Sacral Nerve Modulation and Pudendal Nerve Stimulation in Treatment of Fecal Incontinence

Not Applicable
Completed
Conditions
Fecal Incontinence
Interventions
Procedure: Sacral nerve modulation
Procedure: Pudendal nerve stimulation
Registration Number
NCT01069016
Lead Sponsor
Cantonal Hospital of St. Gallen
Brief Summary

Sacral nerve modulation (SNM) is an established treatment for refractory lower urinary tract and bowel dysfunction (Spinelli 2008). Pudendal nerve stimulation (PNS) has been proposed for patients failing SNM treatment of urinary dysfunction (Spinelli 2005). In this study SNM and PNS are compared for the treatment of fecal incontinence. In a test phase, both treatments will be applied for one week each in a randomized and blinded order (cross-over design). After the test phase the more successful treatment will be determined and applied permanently. If both treatments are equally sufficient, PNS will be chosen for permanent stimulation, since preliminary data indicate that PNS has a lower power consumption than SNM. Lower power consumption results in a longer lifetime of the stimulator, thus requiring less replacement surgeries.

Detailed Description

Primary Surgery:

* Implantation of two electrodes, one placed next to the sacral nerve, one close to the pudendal nerve. Electrode wires are passed through the skin just above the gluteal region and are marked S and P. One of the sub-investigators (not involved in the follow-up) replaces the S and P marks by 1 and 2 marks in absence of the operating surgeon. Assignment of 1 and 2 is carried out in a predefined randomized fashion (computerized block randomization).

Test phase:

* Electrode labeled 1 is connected to a stimulator and the nerve is stimulated for one week, then the other electrode is stimulated for a week.

* Based on bowel habit diary, Wexner score (Jorge 1993) and subjective experience of the patient, the more successful treatment is chosen. If both electrodes were equally successful, the pudendal nerve electrode will be chosen for permanent stimulation.

Secondary surgery:

* After unblinding, the less effective electrode is removed and the remaining electrode is connected to an implanted stimulator (permanent phase). In case both treatments were unsuccessful, both electrodes are removed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • fecal incontinence nonresponsive to conservative treatment
Exclusion Criteria
  • sacral or perineal infection
  • sphincter defect larger than 60° (sonography)
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Pudendal nerve stimulation firstSacral nerve modulationPudendal nerve stimulation is applied before the sacral nerve modulation. There is no "wash-out" period (pause) between the two treatments.
Sacral nerve modulation firstSacral nerve modulationSacral nerve modulation is applied before the pudendal nerve stimulation. There is no "wash-out" period (pause) between the two treatments.
Sacral nerve modulation firstPudendal nerve stimulationSacral nerve modulation is applied before the pudendal nerve stimulation. There is no "wash-out" period (pause) between the two treatments.
Pudendal nerve stimulation firstPudendal nerve stimulationPudendal nerve stimulation is applied before the sacral nerve modulation. There is no "wash-out" period (pause) between the two treatments.
Primary Outcome Measures
NameTimeMethod
Power consumption of stimulator14 days
Secondary Outcome Measures
NameTimeMethod
Wexner Score (Jorge 1993)7, 14 days, 3, 6 & 12 months
Quality of Life (FIQL (Rockwood 2000))14 days, 3, 6 & 12 months
Incidence of surgical complications (adverse events) graded according to Dindo (2004)30 days

Trial Locations

Locations (1)

Department of Surgey, Cantonal Hospital St. Gallen

🇨🇭

St.Gallen, Switzerland

© Copyright 2025. All Rights Reserved by MedPath